Infiltrating ductal adenocarcinoma is the most common malignancy of the pancreas. When most investigators use the term 'pancreatic cancer' they are referring to pancreatic ductal adenocarcinoma (PDA). Normal duct epithelium progresses to infiltrating cancer through a series of histologically defined precursors (PanINs). The overexpression of HER-2/neu and activating point mutations in the K-ras gene occur early, inactivation of the p16 gene at an intermediate stage, and the inactivation of p53, SMAD4, and BRCA2 occur relatively late. Activated K-ras engages multiple effector pathways. Although EGF receptors are conventionally regarded as upstream activators of RAS proteins, they can also act as RAS signal transducers via RAS-induced autocrine activation of the EGFR family ligands. Moreover, PDA shows extensive genomic instability and aneuploidy. Telomere attrition and mutations in p53 and BRCA2 are likely to contribute to these phenotypes. Inactivation of the SMAD4 tumour suppressor gene leads to loss of the inhibitory influence of the transforming growth factor-beta signalling pathway.

Human Diseases; Cancer: specific types
BRITE hierarchy

Rousettus aegyptiacus (Egyptian rousette) [GN:ray]

Von Hoff D, Evans D, Hruban R (ed).

Pancreatic cancer

Jones and Bartlett publishers (2005)

(Japanese)

Niitsu Y, Yokota J (ed).

[Oncogenes and Tumor Suppressor Genes for Medical Oncologist] (In Japanese)

Nankodo (1999)

PMID:12459728

Bardeesy N, DePinho RA.

Pancreatic cancer biology and genetics.

Nat Rev Cancer 2:897-909 (2002)
DOI:10.1038/nrc949

PMID:11407945

Bardeesy N, Sharpless NE, DePinho RA, Merlino G.

The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.

Semin Cancer Biol 11:201-18 (2001)
DOI:10.1006/scbi.2000.0371

PMID:12946833

Cowgill SM, Muscarella P.

The genetics of pancreatic cancer.

Am J Surg 186:279-86 (2003)
DOI:10.1016/S0002-9610(03)00226-5

PMID:16702400

Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA.

Genetics and biology of pancreatic ductal adenocarcinoma.

Genes Dev 20:1218-49 (2006)
DOI:10.1101/gad.1415606

PMID:10740269

Shields JM, Pruitt K, McFall A, Shaub A, Der CJ.

Understanding Ras: 'it ain't over 'til it's over'.

Trends Cell Biol 10:147-54 (2000)
DOI:10.1016/S0962-8924(00)01740-2

PMID:12648469

Holbro T, Civenni G, Hynes NE.

The ErbB receptors and their role in cancer progression.

Exp Cell Res 284:99-110 (2003)
DOI:10.1016/S0014-4827(02)00099-X

PMID:14967450

Marmor MD, Skaria KB, Yarden Y.

Signal transduction and oncogenesis by ErbB/HER receptors.

Int J Radiat Oncol Biol Phys 58:903-13 (2004)
DOI:10.1016/j.ijrobp.2003.06.002

PMID:14586404

DeArmond D, Brattain MG, Jessup JM, Kreisberg J, Malik S, Zhao S, Freeman JW.

Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines.

Oncogene 22:7781-95 (2003)
DOI:10.1038/sj.onc.1206966

PMID:12545153

Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K.

Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.

Oncogene 22:319-29 (2003)
DOI:10.1038/sj.onc.1206122

PMID:14580692

Toyonaga T, Nakano K, Nagano M, Zhao G, Yamaguchi K, Kuroki S, Eguchi T, Chijiiwa K, Tsuneyoshi M, Tanaka M.

Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.

Cancer Lett 201:107-16 (2003)
DOI:10.1016/S0304-3835(03)00482-8

PMID:12079267

Schmid RM.

Genetic basis of pancreatic cancer.

Best Pract Res Clin Gastroenterol 16:421-33 (2002)
DOI:10.1053/bega.2002.0316

PMID:15774796

Elliott RL, Blobe GC.

Role of transforming growth factor Beta in human cancer.

J Clin Oncol 23:2078-93 (2005)
DOI:10.1200/JCO.2005.02.047

PMID:15823750

Rudkin TM, Foulkes WD.

BRCA2: breaks, mistakes and failed separations.

Trends Mol Med 11:145-8 (2005)
DOI:10.1016/j.molmed.2005.02.003

PMID:11707511

Venkitaraman AR.

Functions of BRCA1 and BRCA2 in the biological response to DNA damage.

J Cell Sci 114:3591-8 (2001)

PMID:23340292

Chang Z, Li Z, Wang X, Kang Y, Yuan Y, Niu J, Wang H, Chatterjee D, Fleming JB, Li M, Abbruzzese JL, Chiao PJ

Deciphering the mechanisms of tumorigenesis in human pancreatic ductal epithelial cells.

Clin Cancer Res 19:549-59 (2013)
DOI:10.1158/1078-0432.CCR-12-0032